thiamine triphosphate has been researched along with Congenital Thrombotic Thrombocytopenic Purpura in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callewaert, F; Cataland, S; Coppo, P; de la Rubia, J; De Passos Sousa, R; Gunawardena, S; Knöbl, P; Kremer Hovinga, JA; Lin, J; Metjian, A; Minkue Mi Edou, J; Pavenski, K; Peyvandi, F; Scully, M | 1 |
| Chen, J; Cui, L; Feng, Y; Mao, Z; Mei, C; Mei, S; Qian, Y; Zhao, X | 1 |
1 trial(s) available for thiamine triphosphate and Congenital Thrombotic Thrombocytopenic Purpura
| Article | Year |
|---|---|
Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES study.
Topics: ADAMTS13 Protein; Follow-Up Studies; Humans; Purpura, Thrombotic Thrombocytopenic; Single-Domain Antibodies | 2022 |
1 other study(ies) available for thiamine triphosphate and Congenital Thrombotic Thrombocytopenic Purpura
| Article | Year |
|---|---|
Thrombotic thrombocytopenic purpura developed after pegylated interferon treatment for hepatitis B infection.
Topics: Adult; COVID-19; COVID-19 Vaccines; Female; Hepatitis B; HIV Infections; Humans; Interferons; Male; Polyethylene Glycols; Pregnancy; Purpura, Thrombotic Thrombocytopenic | 2022 |